Repeatability and Reproducibility of Pseudocontinuous Arterial Spin-Labeling–Measured Brain Perfusion in Healthy Volunteers and Patients with Glioblastoma

References

1. 1.↵
   1. Rosenkrantz AB,
   2. Mendiratta-Lala M,
   3. Bartholmai BJ, et al

   . Clinical utility of quantitative imaging. Acad Radiol 2015;22:33–49 doi:10.1016/j.acra.2014.08.011 pmid:25442800

   CrossRefPubMed
2. 2.↵
   1. Yankeelov TE,
   2. Mankoff DA,
   3. Schwartz LH, et al

   . Quantitative imaging in cancer clinical trials. Clin Cancer Res 2016;22:284–90 doi:10.1158/1078-0432.CCR-14-3336 pmid:26773162

   Abstract/FREE Full Text
3. 3.↵
   1. Eisenhauer EA,
   2. Therasse P,
   3. Bogaerts J, et al

   . New response evaluation criteria in solid tumours: revised RECIST guideline (Version 1.1). Eur J Cancer 2009;45:228–47 doi:10.1016/j.ejca.2008.10.026 pmid:19097774

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Wen PY,
   2. Chang SM,
   3. Van den Bent MJ, et al

   . Response assessment in neuro-oncology clinical trials. J Clin Oncol 2017;35:2439–49 doi:10.1200/JCO.2017.72.7511 pmid:28640707

   CrossRefPubMed
5. 5.↵
   1. Ellingson BM,
   2. Wen PY,
   3. Cloughesy TF

   . Modified criteria for radiographic response assessment in glioblastoma clinical trials. Neurotherapeutics 2017;14:307–20 doi:10.1007/s13311-016-0507-6 pmid:28108885

   CrossRefPubMed
6. 6.↵
   1. Hanahan D,
   2. Weinberg RA

   . Hallmarks of cancer: the next generation. Cell 2011;144:646–74 doi:10.1016/j.cell.2011.02.013 pmid:21376230

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Detre JA,
   2. Leigh JS,
   3. Williams DS, et al

   . Perfusion imaging. Magn Reson Med 1992;23:37–45 doi:10.1002/mrm.1910230106 pmid:1734182

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Williams DS,
   2. Detre JA,
   3. Leigh JS, et al

   . Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci U S A 1992;89:212–16 doi:10.1073/pnas.89.1.212 pmid:1729691

   Abstract/FREE Full Text
9. 9.↵
   1. Alsop DC,
   2. Detre JA,
   3. Golay X, et al

   . Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med 2015;73:102–16 doi:10.1002/mrm.25197 pmid:24715426

   CrossRefPubMed
10. 10.↵
    1. Li Z,
    2. Schar M,
    3. Wang D, et al

    . Arterial spin labeled perfusion imaging using three-dimensional turbo spin echo with a distributed spiral-in/out trajectory. Magn Reson Med 2016;75:266–73 doi:10.1002/mrm.25645 pmid:25754947

    CrossRefPubMed
11. 11.↵
    1. Greer JS,
    2. Wang X,
    3. Wang Y, et al

    . Robust pCASL perfusion imaging using a 3D Cartesian acquisition with spiral profile reordering (CASPR). Magn Reson Med 2019;82:1713–24 doi:10.1002/mrm.27862 pmid:31231894

    CrossRefPubMed
12. 12.↵
    1. Taso M,
    2. Munsch F,
    3. Zhao L, et al

    . Regional and depth-dependence of cortical blood-flow assessed with high-resolution arterial spin labeling (ASL). J Cereb Blood Flow Metab 2021;41:1899–911 doi:10.1177/0271678X20982382 pmid:33444098

    CrossRefPubMed
13. 13.↵
    1. Taso M,
    2. Zhao L,
    3. Guidon A, et al

    . Volumetric abdominal perfusion measurement using a pseudo-randomly sampled 3D fast-spin-echo (FSE) arterial spin labeling (ASL) sequence and compressed sensing reconstruction. Magn Reson Med 2019;82:680–92 doi:10.1002/mrm.27761 pmid:30953396

    CrossRefPubMed
14. 14.↵
    1. Ellingson BM,
    2. Bendszus M,
    3. Boxerman J, et al

    ; Jumpstarting Brain Tumor Drug Development Coalition Imaging Standardization Steering Committee. Consensus recommendations for a standardized brain tumor imaging protocol in clinical trials. Neuro Oncol 2015;17:1188–98 doi:10.1093/neuonc/nov095 pmid:26250565

    CrossRefPubMed
15. 15.↵
    1. Li X,
    2. Morgan PS,
    3. Ashburner J, et al

    . The first step for neuroimaging data analysis: DICOM to NIfTI conversion. J Neurosci Methods 2016;264:47–56 doi:10.1016/j.jneumeth.2016.03.001 pmid:26945974

    CrossRefPubMed
16. 16.↵
    1. Jenkinson M,
    2. Beckmann CF,
    3. Behrens TE, et al

    . FSL. Neuroimage 2012;62:782–90 doi:10.1016/j.neuroimage.2011.09.015 pmid:21979382

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Woolrich MW,
    2. Jbabdi S,
    3. Patenaude B, et al

    . Bayesian analysis of neuroimaging data in FSL. Neuroimage 2009;45:S173–86 doi:10.1016/j.neuroimage.2008.10.055 pmid:19059349

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Smith SM,
    2. Jenkinson M,
    3. Woolrich MW, et al

    . Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(Suppl 1):S208–19 doi:10.1016/j.neuroimage.2004.07.051 pmid:15501092

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Rohlfing T,
    2. Zahr NM,
    3. Sullivan EV, et al

    . The SRI24 multichannel atlas of normal adult human brain structure. Hum Brain Mapp 2010;31:798–819 doi:10.1002/hbm.20906 pmid:20017133

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Avants BB,
    2. Tustison NJ,
    3. Stauffer M, et al

    . The Insight ToolKit image registration framework. Front Neuroinform 2014;8:44 doi:10.3389/fninf.2014.00044 pmid:24817849

    CrossRefPubMed
21. 21.↵
    1. Robson PM,
    2. Madhuranthakam AJ,
    3. Dai W, et al

    . Strategies for reducing respiratory motion artifacts in renal perfusion imaging with arterial spin labeling. Magn Reson Med 2009;61:1374–87 doi:10.1002/mrm.21960 pmid:19319891

    CrossRefPubMed
22. 22.↵
    1. Nyul LG,
    2. Udupa JK,
    3. Zhang X

    . New variants of a method of MRI scale standardization. IEEE Trans Med Imaging 2000;19:143–50 doi:10.1109/42.836373 pmid:10784285

    CrossRefPubMedWeb of Science
23. 23.↵
    National Electrical Manufacturers Association. Determination of Signal-to-Noise Ratio (SNR) in Diagnostic Magnetic Resonance Imaging. March 31, 2021. https://www.nema.org/Standards/view/Determination-of-Signal-to-Noise-Ratio-in-Diagnostic-Magnetic-Resonance-Imaging. Accessed February 20, 2024.
24. 24.↵
    1. Petr J,
    2. Hogeboom L,
    3. Nikulin P, et al

    . A systematic review on the use of quantitative imaging to detect cancer therapy adverse effects in normal-appearing brain tissue. MAGMA 2022;35:163–86 doi:10.1007/s10334-021-00985-2 pmid:34919195

    CrossRefPubMed
25. 25.↵
    1. Petr J,
    2. Platzek I,
    3. Hofheinz F, et al

    . Photon vs. proton radiochemotherapy: effects on brain tissue volume and perfusion. Radiother Oncol 2018;128:121–27 doi:10.1016/j.radonc.2017.11.033 pmid:29370984

    CrossRefPubMed
26. 26.↵
    1. Telischak NA,
    2. Detre JA,
    3. Zaharchuk G

    . Arterial spin labeling MRI: clinical applications in the brain. J Magn Reson Imaging 2015;41:1165–80 doi:10.1002/jmri.24751 pmid:25236477

    CrossRefPubMed
27. 27.↵
    1. Detre JA,
    2. Rao H,
    3. Wang DJ, et al

    . Applications of arterial spin labeled MRI in the brain. J Magn Reson Imaging 2012;35:1026–37 doi:10.1002/jmri.23581 pmid:22246782

    CrossRefPubMed
28. 28.↵
    1. Chen Y,
    2. Wang DJ,
    3. Detre JA

    . Test-retest reliability of arterial spin labeling with common labeling strategies. J Magn Reson Imaging 2011;33:940–49 doi:10.1002/jmri.22345 pmid:21448961

    CrossRefPubMed
29. 29.↵
    1. Wu B,
    2. Lou X,
    3. Wu X, et al

    . Intra- and interscanner reliability and reproducibility of 3D whole-brain pseudo-continuous arterial spin-labeling MR perfusion at 3T. J Magn Reson Imaging 2014;39:402–09 doi:10.1002/jmri.24175 pmid:23723043

    CrossRefPubMed
30. 30.↵
    1. Xu G,
    2. Rowley HA,
    3. Wu G, et al

    . Reliability and precision of pseudo-continuous arterial spin labeling perfusion MRI on 3.0 T and comparison with 15O-water PET in elderly subjects at risk for Alzheimer’s disease. NMR Biomed 2010;23:286–93 doi:10.1002/nbm.1462 pmid:19953503

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Kilroy E,
    2. Apostolova L,
    3. Liu C, et al

    . Reliability of two-dimensional and three-dimensional pseudo-continuous arterial spin labeling perfusion MRI in elderly populations: comparison with 15O-water positron emission tomography. J Magn Reson Imaging 2014;39:931–39 doi:10.1002/jmri.24246 pmid:24038544

    CrossRefPubMed
32. 32.↵
    1. Zhou L,
    2. Wang Y,
    3. Pinho MC, et al

    . Intrasession reliability of arterial spin-labeled MRI-measured noncontrast perfusion in glioblastoma at 3 T. Tomography 2020;6:139–47 doi:10.18383/j.tom.2020.00010 pmid:32548290

    CrossRefPubMed
33. 33.↵
    1. Alsaedi AF,
    2. Thomas DL,
    3. De Vita E, et al

    . Repeatability of perfusion measurements in adult gliomas using pulsed and pseudo-continuous arterial spin labelling MRI. MAGMA 2022;35:113–25 doi:10.1007/s10334-021-00975-4 pmid:34817780

    CrossRefPubMed
34. 34.↵
    1. Bedekar D,
    2. Jensen T,
    3. Schmainda KM

    . Standardization of relative cerebral blood volume (rCBV) image maps for ease of both inter- and intrapatient comparisons. Magn Reson Med 2010;64:907–13 doi:10.1002/mrm.22445 pmid:20806381

    CrossRefPubMed